PwC's Next in Health

EXPLORE

Society & Culture

© 2024 PodJoint

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/25/98/b1/2598b1a2-1c31-c03b-587a-49a84903b855/mza_9385086212833900668.jpg/600x600bb.jpg

PwC's Next in Health

PwC's Health Industries

63 episodes

2 weeks ago

What will healthcare look like a decade from now? Host Glenn Hunzinger is joined by Greg Rotz, Pharmaceutical and Life Sciences Advisory Leader and Thom Bales, Principal, Health Services Advisory Leader, as they dive into the future of health—one driven by smarter tech, empowered consumers, and breakthrough science. From reimagining chronic care to building new business models, discover the mindset, partnerships, and capabilities that will define the next era of healthcare. Discussion highlig...

Show more...

Health & Fitness

All content for PwC's Next in Health is the property of PwC's Health Industries and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

What will healthcare look like a decade from now? Host Glenn Hunzinger is joined by Greg Rotz, Pharmaceutical and Life Sciences Advisory Leader and Thom Bales, Principal, Health Services Advisory Leader, as they dive into the future of health—one driven by smarter tech, empowered consumers, and breakthrough science. From reimagining chronic care to building new business models, discover the mindset, partnerships, and capabilities that will define the next era of healthcare. Discussion highlig...

Show more...

Health & Fitness

Episodes (20/63)

PwC's Next in Health

Reinventing Healthcare - Seizing the $1 Trillion Breakthrough

What will healthcare look like a decade from now? Host Glenn Hunzinger is joined by Greg Rotz, Pharmaceutical and Life Sciences Advisory Leader and Thom Bales, Principal, Health Services Advisory Leader, as they dive into the future of health—one driven by smarter tech, empowered consumers, and breakthrough science. From reimagining chronic care to building new business models, discover the mindset, partnerships, and capabilities that will define the next era of healthcare. Discussion highlig...

2 weeks ago

33 minutes

PwC's Next in Health

The One Big Beautiful Bill: What It Means for the Future of U.S. Healthcare

Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, sits down with Nicole Montgomery, Shannon O’Shea, and Phil Sclafani to unpack the sweeping implications of the newly signed One Big Beautiful Bill Act (OBBBA). With nearly a third of the bill dedicated to healthcare, the team explores how this landmark legislation will reshape coverage, funding, and delivery across the payer, provider, and pharma landscape. Discussion highlights: The OBBBA introduces new work requirements and elig...

3 months ago

15 minutes

PwC's Next in Health

Strategic Dealmaking in Health: Navigating Midyear Trends in 2025

Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, connects with Nick Donkar, PwC’s U.S. Health Services Deals Leader, and Roel Van den Akker, PwC’s Pharma and Life Sciences Deals Leader, to discuss the 2025 midyear deals outlook across health services and pharma and life sciences. They explore how macroeconomic trends, regulatory pressures, and evolving investment strategies are shaping M&A activity and where new opportunities may emerge as companies look ahead to the second hal...

4 months ago

19 minutes

PwC's Next in Health

Taking a closer look at the Most Favored Nation Pricing Executive Order

Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, and Phil Scalfani, PwC’s Pharmaceutical and Life Sciences Consulting Leader, discuss the Trump administration’s executive order on Most Favored Nation (MFN) drug pricing and its far-reaching implications across the healthcare ecosystem. They break down what MFN pricing could mean for pharmaceutical companies, payers, PBMs, and the broader drug supply chain, and share perspectives on how organizations can navigate the uncertainty ahea...

5 months ago

16 minutes

PwC's Next in Health

Navigating the FDA disruption: 4 key actions for pharma

Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, connects with Matt Rich, PwC’s Pharma and Life Sciences R&D Leader, to unpack the recent disruption at the FDA and what it means for the pharmaceutical and biotech sectors. They discuss how companies can stay agile in the face of regulatory uncertainty, avoid preventable delays, and take practical steps to move programs forward with clarity. Discussion highlights: Ongoing restructuring at the FDA is creating uncertainty and delay...

5 months ago

10 minutes

PwC's Next in Health

Strategic Shifts: Navigating China's Biotech Boom and Its Impact on US Pharma

Tune in as Glenn Hunzinger, PwC’s Health Industries Leader and Roel van den Akker, PwC’s Pharma and Life Sciences Deals Leader discuss the rapid rise of China’s biotech industry and what it means for U.S. pharmaceutical companies. They discuss the evolving role of Chinese biotech in the global innovation landscape and share perspectives on how U.S. pharmaceutical companies can thoughtfully assess opportunities, manage cross-border complexities, and build effective partnering and diligence str...

5 months ago

11 minutes

PwC's Next in Health

Navigating Healthcare’s Next Chapter Under the Trump Administration

Disclaimer: This episode was recorded on April 11th, 2025, and reflects the information available at the time of recording. As we know, America is in motion here, and so subsequent updates may not be reflected in this discussion as things continue to evolve and change. Tune in as PwC specialists from across the health industry share their insights on how recent policy shifts under the Trump administration could shape healthcare in the years to come. In this episode, Glenn Hunzinger, Jen...

6 months ago

28 minutes

PwC's Next in Health

Next in Pharma: The 2025 Outlook—The Future is Now

Tune in as PwC's Pharmaceutical & Life Sciences Advisory Leader, Greg Rotz reflects on key market dynamics and explores how pharma leaders can tackle challenges including the $400 billion patent cliff, increasing competition, drug pricing pressures, and transformative disruptions shaping the industry. Discussion highlights: Understanding the scale and implications of the upcoming patent cliff and economic pressures from regulatory changes like the Inflation Reduction ActExamining heighten...

7 months ago

21 minutes

PwC's Next in Health

Next in Health: The 2025 Outlook for Health Services

Tune in as PwC specialists discuss the 2025 healthcare outlook, reflecting on 2024’s significant events and exploring how payers and providers can navigate rising costs, scrutiny, AI advances, and policy shifts with resilience and adaptability. Topics include: Medicare and Medicaid drive industry growth amid rising competition, market exits, M&A, AI adoption, and policy challenges.AI's potential to enhance healthcare delivery, improve workforce management, and optimize patient care.The ca...

8 months ago

30 minutes

PwC's Next in Health

Health Industries: U.S. Deals Outlook for 2025 and Beyond

Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the 2024 deals landscape and offer a preview of what lies ahead. Topics include: Key topics include: A look back at M&A activity in health industries in 2024The challenges and potential impediments that could affect deal volumes in the coming yearHow artificial intelligence and tech innovations are reshaping the volume and nature of healthcare transactionsKey trends and developments to watch for wi...

10 months ago

25 minutes

PwC's Next in Health

PwC’s 2024 US Healthcare Climate Survey

Tune in as authors of PwC's U.S. Healthcare Climate Survey discuss key findings and provide insights into understanding healthcare organizations' responses to climate change, the integration of climate strategies, and the challenges faced in implementation. Key topics include: The survey's background, focus, and objectives that address the prioritization of climate strategies by healthcare organizations in response to climate change impactsDifferences in climate strategy approaches across sec...

10 months ago

14 minutes

PwC's Next in Health

PwC's U.S. Healthcare Consumer Insights and Engagement Survey

Tune in as authors of PwC's U.S. Healthcare Consumer Insights and Engagement Survey discuss key findings and provide insights into understanding consumer concerns around healthcare costs, the adoption of tech-enabled healthcare, trust in the healthcare system and how we can take action. Key topics include: The survey's background, focus and objectives that will address ongoing consumer concerns and distrust in the healthcare systemGenerational and financial differences reveal significan...

11 months ago

20 minutes

PwC's Next in Health

Next in medtech: Unlocking future growth in 3 strategic steps

How can medtech companies drive growth in today's market? Tune in as PwC specialists return to share key insights and strategies to help medtech companies invest in the capabilities required to compete in the future while aiming to exceed near-term expectations for growth and margin improvement. Key topics include: Challenges currently faced by medtech companiesReevaluating business models and new ways to playDriving returns on historical investments in technology by leveraging data and trans...

11 months ago

13 minutes

PwC's Next in Health

Election Impact: What to expect for the Health Industry

What can the health industry expect from a second Trump administration? Tune in to hear what executives should watch over the next few months and years to come. Key topics include: President-elect Trump's healthcare agenda and his focus on deregulation, flexibility and choice, and accessibilityPotential implications for medicare, the ACA and IRA drug negotiationsWhat to watch in the first 100 days Speakers: Kelly Griffin, Director, Health Policy and Intelligence Institute Jenny Co...

11 months ago

17 minutes

PwC's Next in Health

Boardroom essentials: Securing a seat on an emerging company board

Tune in as PwC specialists discuss best practices for securing a seat on an emerging company board. Key topics include: Types of emerging companiesResponsibilities of serving on emerging company boardsFive strategies for securing a board positionImportance of industry-specific expertise and continuous learning Speakers: Holly Reeves, Partner, Emerging Company Solutions Market Leader, Health Industries, PwC US Carin Robinson, Director, Governance Insights Center, PwC US Jenny Colap...

11 months ago

16 minutes

PwC's Next in Health

PwC's 2025 Medical cost trend report reveals rising healthcare costs

Tune in as authors of PwC's 2025 Medical Cost Trend Report: Behind the Numbers, discuss key findings and provide what employers should consider to manage rising healthcare costs. Key points include: Cost projections: The highest medical cost trend in 13 years, with an 8% increase for the group market and 7.5% for the individual marketKey drivers: Inflation, providers' cost-control efforts, increased use of prescription drugs, and new innovative therapiesStrategic adjustments: Employers...

1 year ago

21 minutes

PwC's Next in Health

The importance of physician enablement to our health ecosystem

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky, in discussion with PwC Strategy& Director, Rohit Nayak, PwC Strategy& Senior Manager, Sri Murthy Guru and PwC Strategy& Senior Associate, Cailin Hong, on what physicians are seeking from payers, health systems and management services organizations (MSOs), to help improve the practice of medicine. This episode includes: Emerging business models and solutions that can enhance the phys...

1 year ago

18 minutes

PwC's Next in Health

How emerging companies are navigating growth in the health industry

Tune in as PwC specialists discuss how emerging companies (private, pre-IPO) are navigating growth in the health industry. Key topics include: The journey and milestones of emerging companies in the life sciences, biotech and medical technology fields, including capital raising, product development and IPO preparationCommon pitfalls and best practices for managing diverse interests from investors and stakeholdersExamples of how emerging companies are leveraging AI and other technologie...

1 year ago

21 minutes

PwC's Next in Health

2024 Outlook: Healthcare's big squeeze and the way out

Tune in as PwC specialists discuss the 2024 outlook for healthcare and how the sector can grow and innovate amid economic challenges and uncertainty. Key Topics include: Major forces impacting the sector: economic pressure, rising costs, labor shortage, and expensive drugsWays to overcome compression and deliver value: industry-wide transformation, tech enabled business model reinvention, transactions and deals to drive transformation, and building trustSpeakers: Laura Robinette,...

1 year ago

17 minutes

PwC's Next in Health

Reinventing for returns: what's next in pharma?

Tune in to hear PwC specialists discuss strategies to reinvent the pharma business model and drive growth in the pharmaceutical industry. Key topics include: The headwinds for pharma are real and sustained Rethinking the innovation strategy Accelerate using AI and analytics Lower costs M&A as a catalyst for transformation Protecting the enterpriseSpeakers: Jenny Colapietro, Health Industries Vice Chair, PwC Glenn Hunzinger, Pharmaceutical and Life Sci...

1 year ago

13 minutes